Myriad Announces Favorable Medicare Final Coverage Decision for the ProlarisR) Test

By: via Benzinga
Myriad Genetics, Inc. (Nasdaq: MYGN) today announced that Noridian, the Medicare Administrative Contractor (MAC) for Myriad, has issued ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.